EPISODE · May 3, 2020 · 7 MIN

Remdesivir for COVID-19

from Dr. Chapa’s OBGYN Clinical Pearls · host Dr. Chapa’s Clinical Pearls

On May 1, 2020, the FDA authorized the emergency use of Remdesivir for COVID-19. This was based on a preliminary analysis of an NIH clinical trial. However, information is still lacking on safety and efficacy in a larger study population. In this session, we will review the known mechanism of action of this novel antiviral medication and limitations of data.

Episode metadata supplied by the publisher feed · Published May 3, 2020

Embed this episode

Attribution link and audio player

NOW PLAYING

Remdesivir for COVID-19

0:00 7:27

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Dr. Chapa’s OBGYN Clinical Pearls?

This episode is 7 minutes long.

When was this Dr. Chapa’s OBGYN Clinical Pearls episode published?

This episode was published on May 3, 2020.

Can I download this Dr. Chapa’s OBGYN Clinical Pearls episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!